GLOBAL DNA VACCINES MARKET 2019-2027

Lifesciences | Pharmaceuticals

GLOBAL DNA VACCINES MARKET 2019-2027

Market By Type, Application, Technology And Geography | Forecast 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

According to Triton, the global DNA vaccines market is expected to display a positive market trend over the forecast period of 2019-2027, exhibiting a CAGR of 42.03%. The market was assessed to be worth $1586.01 million in the year 2018 and is predicted to generate a revenue of approximately $37384.45 million by the year 2027.

DNA vaccination is necessary for gaining protection against various chronic and communicable diseases, which is carried out by introducing the genetically engineered nucleic acids in the form of DNA that triggers the cells to directly release the required antigen for specific immune response necessary for fighting the disease. DNA vaccines have multiple prospective advantages over the traditional vaccines, for instance, their wide range of immune responses.

global DNA vaccines market is expected to display a positive market trend over the forecast period of 2019-2027, exhibiting a CAGR of 42.03%.

We provide additional customization based on your specific requirements. Request For Customization  

DNA vaccines are known to be the third generation vaccines. They are nucleic acids that code for specific proteins or antigens, which are isolated from a pathogen. The vaccines are made to target the cells as their base site, whose internal mechanism rests on the DNA vaccine to synthesize the necessary proteins. As these proteins are identified to be foreign, when the host cells administer these antigens/proteins, the immune system triggers the required immune responses upon receiving the alert. 

DNA vaccines have many advantages, for instance, the minimal infection risk, create a rift in the T-cell response into the type 1 or type 2, immune response is customized as per the antigen of interest, easier development and production of the vaccines, ease for storage and shipping, etc.

Rapid growth is estimated in the global DNA vaccines market once these vaccines get approval for clinical trials and processing a large number of investors. Almost 100 clinical trials on humans are in progress for diseases ranging from HIV, cancer, Hepatitis, influenza, Zika infection and other infectious diseases. The Bill & Melinda Gates Foundation has donated around $100 million to Moderna Therapeutics to develop DNA vaccines for infectious diseases. Also, several government departments are funding private companies for developing DNA vaccines. For example, the US Department of Health and Services agreed to provide a fund of around $125 million to Moderna Therapeutics to develop a vaccine for Zika infection.

Within this report, Triton Market Research has discussed key insights regarding the industry. Also, the value chain outlook, key buying outlook, Porter’s five force analysis and regulatory framework have been studied for the DNA vaccines market in the report. 

Market drivers like a surge in new vaccine development, increasing usage of DNA vaccines for animal healthcare and the rising prevalence of chronic & infectious diseases are evolving the market globally. The market is also facing restraints like the lack of legal & ethical framework and stringent government regulations.

The growing demand for gene therapy, steady vaccines that are easier to store & transport and the increasing number of clinical trials on humans are expected to leverage the market to achieve the projected growth over the forecast period. However, key challenges, such as variation in the regulatory pathway and the points of consideration regarding environmental valuation, are challenging the market growth.

global DNA vaccines market has been segmented as follows:  •    By type:  O    Animal DNA vaccine  O    Human DNA vaccine  •    By application:

To get detailed insights on segments, Request Free Sample Report  

Top geographies that have been covered in the global DNA vaccines market report are:

•    North America DNA vaccines: the United States and Canada

•    Europe DNA vaccines: the United Kingdom, Germany, France, Italy, Spain, Russia and Rest of Europe

•    Asia-Pacific DNA vaccines: China, Japan, India, South Korea, ASEAN countries, Australia & New Zealand and Rest of Asia-Pacific

•    Latin America DNA vaccines: Brazil, Mexico and Rest of Latin America

•    The Middle East and Africa DNA vaccines: the United Arab Emirates, Turkey, Saudi Arabia, South Africa and Rest of the Middle East & Africa

The global DNA vaccines market has been segmented as follows:

•    By type:

O    Animal DNA vaccine

O    Human DNA vaccine

•    By application:

O    Human disease 

O    Veterinary disease

•    By technology: 

O    Plasmid DNA vaccines

O    Plasmid DNA delivery

The companies leading the DNA vaccines market are Astellas Pharma, Inc., Dendreon Corporation (acquired by Sanpower Group), Eli Lilly and Company, Eurogentec S.A., GlaxoSmithKline, Inc., Inovio Pharmaceuticals, Inc., Madison Vaccines, Incorporated (MVI), Merck & Co., Merial Limited (acquired by Boehringer Ingelheim), Novartis AG, Sanofi, VGXI, Vical, Incorporated, Xenetic Biosciences, Inc. and Zoetis, Inc.

The company market share helps in analyzing the major companies in this market and also their hold on the market.


Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    GLOBAL DNA VACCINES MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES OUTLOOK

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREATS OF SUBSTITUTE PRODUCT

2.2.3.   BARGAINING POWER OF BUYER

2.2.4.   BARGAINING POWER OF SUPPLIER

2.2.5.   INTENSITY OF COMPETITIVE RIVALRY

2.3. VENDOR SCORECARD

2.4. VALUE CHAIN OUTLOOK

2.5. KEY INSIGHTS

2.6. REGULATORY FRAMEWORK

2.7. KEY BUYING OUTLOOK

2.8. MARKET DRIVERS

2.8.1.   SURGE IN NEW VACCINE DEVELOPMENT

2.8.2.   RISING USAGE OF DNA VACCINES FOR ANIMAL HEALTHCARE

2.8.3.   RISING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES

2.9. MARKET RESTRAINTS

2.9.1.   LACK OF LEGAL AND ETHICAL FRAMEWORK

2.9.2.   STRINGENT GOVERNMENT REGULATIONS

2.10.            MARKET OPPORTUNITIES

2.10.1.                GROWING DEMAND FOR GENE THERAPY

2.10.2.                STEADY VACCINES ARE EASY TO STORE AND TRANSPORT

2.10.3.                INCREASING NUMBER OF CLINICAL TRIALS ON HUMANS

2.11.            MARKET CHALLENGES

2.11.1.                VARIATION IN THE REGULATORY PATHWAY AND THE POINTS OF CONSIDERATION REGARDING ENVIRONMENTAL VALUATION

3.    DNA VACCINES MARKET OUTLOOK - BY TYPE

3.1. ANIMAL DNA VACCINE

3.2. HUMAN DNA VACCINE

4.    DNA VACCINES MARKET OUTLOOK - BY APPLICATION

4.1. HUMAN DISEASE

4.2. VETERINARY DISEASE

5.    DNA VACCINES MARKET OUTLOOK - BY TECHNOLOGY

5.1. PLASMID DNA VACCINES

5.2. PLASMID DNA DELIVERY

6.    DNA VACCINES MARKET OUTLOOK - BY REGION

6.1. NORTH AMERICA

6.1.1.   MARKET BY TYPE

6.1.2.   MARKET BY TECHNOLOGY

6.1.3.   MARKET BY APPLICATION

6.1.4.   COUNTRY ANALYSIS

6.1.4.1.      THE UNITED STATES

6.1.4.2.      CANADA

6.2. EUROPE

6.2.1.   MARKET BY TYPE

6.2.2.   MARKET BY TECHNOLOGY

6.2.3.   MARKET BY APPLICATION

6.2.4.   COUNTRY ANALYSIS

6.2.4.1.      THE UNITED KINGDOM

6.2.4.2.      FRANCE

6.2.4.3.      GERMANY

6.2.4.4.      SPAIN

6.2.4.5.      ITALY

6.2.4.6.      RUSSIA

6.2.4.7.      REST OF EUROPE

6.3. ASIA-PACIFIC

6.3.1.   MARKET BY TYPE

6.3.2.   MARKET BY TECHNOLOGY

6.3.3.   MARKET BY APPLICATION

6.3.4.   COUNTRY ANALYSIS

6.3.4.1.      INDIA

6.3.4.2.      CHINA

6.3.4.3.      JAPAN

6.3.4.4.      AUSTRALIA & NEW ZEALAND

6.3.4.5.      SOUTH KOREA

6.3.4.6.      ASEAN COUNTRIES

6.3.4.7.      REST OF ASIA-PACIFIC

6.4. LATIN AMERICA

6.4.1.   MARKET BY TYPE

6.4.2.   MARKET BY TECHNOLOGY

6.4.3.   MARKET BY APPLICATION

6.4.4.   COUNTRY ANALYSIS

6.4.4.1.      BRAZIL

6.4.4.2.      MEXICO

6.4.4.3.      REST OF LATIN AMERICA

6.5. MIDDLE EAST AND AFRICA

6.5.1.   MARKET BY TYPE

6.5.2.   MARKET BY TECHNOLOGY

6.5.3.   MARKET BY APPLICATION

6.5.4.   COUNTRY ANALYSIS

6.5.4.1.      SAUDI ARABIA

6.5.4.2.      TURKEY

6.5.4.3.      THE UNITED ARAB EMIRATES

6.5.4.4.      SOUTH AFRICA

6.5.4.5.      REST OF MIDDLE EAST & AFRICA

7.    COMPETITIVE LANDSCAPE

7.1. ASTELLAS PHARMA, INC.

7.2. DENDREON CORPORATION (ACQUIRED BY SANPOWER GROUP)

7.3. ELI LILLY AND COMPANY

7.4. EUROGENTEC S.A.

7.5. GLAXOSMITHKLINE, INC.

7.6. INOVIO PHARMACEUTICALS, INC.

7.7. MADISON VACCINES INCORPORATED (MVI)

7.8. MERCK & CO.

7.9. MERIAL LIMITED (ACQUIRED BY BOEHRINGER INGELHEIM)

7.10.            NOVARTIS AG

7.11.            SANOFI

7.12.            VGXI

7.13.            VICAL, INCORPORATED

7.14.            XENETIC BIOSCIENCES, INC.

7.15.            ZOETIS, INC.

8.    METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of table

TABLE 1        GLOBAL DNA VACCINES MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 2        INTERVENTIONS AND PHASE OF SOME DISEASES/CONDITIONS

TABLE 3        REGULATIONS TO FOLLOW BEFORE COMMERCIALIZATION

TABLE 4        TEMPERATURE REQUIREMENTS IN PRESERVATION FOR VARIOUS VACCINES

TABLE 5        APPROACHES BEING TESTED TO ENHANCE THE LOW IMMUNOGENICITY

TABLE 6        CLINICAL TRIALS ON HUMANS INVOLVING DNA VACCINES

TABLE 7        GLOBAL DNA VACCINES MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 8        GLOBAL DNA VACCINES MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)

TABLE 9        GLOBAL DNA VACCINES MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 10      GLOBAL DNA VACCINES MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 11      NORTH AMERICA DNA VACCINES MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 12      NORTH AMERICA DNA VACCINES MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)

TABLE 13      NORTH AMERICA DNA VACCINES MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 14      NORTH AMERICA DNA VACCINES MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 15      EUROPE DNA VACCINES MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 16      EUROPE DNA VACCINES MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)

TABLE 17      EUROPE DNA VACCINES MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 18      EUROPE DNA VACCINES MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 19      ASIA-PACIFIC DNA VACCINES MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 20      ASIA-PACIFIC DNA VACCINES MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)

TABLE 21      ASIA-PACIFIC DNA VACCINES MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 22      ASIA-PACIFIC DNA VACCINES MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 23      LATIN AMERICA DNA VACCINES MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 24      LATIN AMERICA DNA VACCINES MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)

TABLE 25      LATIN AMERICA DNA VACCINES MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 26      LATIN AMERICA DNA VACCINES MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 27      MIDDLE EAST AND AFRICA DNA VACCINES MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 28      MIDDLE EAST AND AFRICA DNA VACCINES MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)

TABLE 29      MIDDLE EAST AND AFRICA DNA VACCINES MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 30      MIDDLE EAST AND AFRICA DNA VACCINES MARKET BY COUNTRY 2019-2027 ($ MILLION)

List of Figures

FIGURE 1      GLOBAL DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 2      VALUE CHAIN ANALYSES FOR DNA VACCINE INDUSTRY

FIGURE 3      NORTH AMERICA DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 4      GLOBAL DNA VACCINES MARKET IN VETERINARY DISEASES 2019-2027 ($ MILLION)

FIGURE 5      SHARE OF TRIALS BY VACCINE TARGET IN 2016

FIGURE 6      SEGMENT OF CLINICAL TRIALS OF DNA VACCINES BY CANCER MARKS IN 2016 (%)

FIGURE 7      CLINICAL TRIALS OF GENE THERAPY

FIGURE 8      GLOBAL DNA VACCINES MARKET IN ANIMAL DNA VACCINES 2019-2027 ($ MILLION)

FIGURE 9      GLOBAL DNA VACCINES MARKET IN HUMAN DNA VACCINES 2019-2027 ($ MILLION)

FIGURE 10   GLOBAL DNA VACCINES MARKET SHARE BY APPLICATION 2018 & 2027 (%)

FIGURE 11   GLOBAL DNA VACCINES MARKET IN HUMAN DISEASES 2019-2027 ($ MILLION)

FIGURE 12   GLOBAL DNA VACCINES MARKET IN VETERINARY DISEASES 2019-2027 ($ MILLION)

FIGURE 13   GLOBAL DNA VACCINES MARKET IN PLASMID DNA VACCINES TECHNOLOGY 2019-2027 ($ MILLION)

FIGURE 14   GLOBAL DNA VACCINES MARKET IN PLASMID DNA DELIVERY TECHNOLOGY 2019-2027 ($ MILLION)

FIGURE 15   THE UNITED STATES DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 16   CANADA DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 17   THE UNITED KINGDOM DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 18   FRANCE DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 19   GERMANY DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 20   SPAIN DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 21   ITALY DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 22   RUSSIA DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 23   REST OF EUROPE DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 24   INDIA DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 25   CHINA DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 26   JAPAN DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 27   AUSTRALIA & NEW ZEALAND DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 28   SOUTH KOREA DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 29   ASEAN COUNTRIES DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 30   REST OF ASIA-PACIFIC DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 31   BRAZIL DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 32   MEXICO DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 33   REST OF LATIN AMERICA DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 34   SAUDI ARABIA DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 35   TURKEY DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 36   THE UNITED ARAB EMIRATES DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 37   SOUTH AFRICA DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 38   REST OF MIDDLE EAST & AFRICA DNA VACCINES MARKET 2019-2027 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;